Sales Rep Overtime Might Get Supreme Court Review; "Staggering Retroactive Liability" Is Worry
The court will consider certiorari petitions from Novartis and Schering at its Feb. 18 conference. An amicus brief from PhRMA paints a dire picture.
The court will consider certiorari petitions from Novartis and Schering at its Feb. 18 conference. An amicus brief from PhRMA paints a dire picture.